tAN for First Responders
{ "Sparrow Link for First Responders' Mental Fatigue and Stress", "This study is exploring how a device called Sparrow Link might help first responders with mental fatigue and stress. Sparrow Link is a wearable device that stimulates nerves around the ear. You might be able to join if you are a first responder, aged 18 or older, and have a GAD-7 score (a measure of anxiety) of 5 or higher. You would use the Sparrow Link device daily for 28 days and complete online questionnaires about your mood, stress, sleep, and energy for eight weeks. The study will measure changes in your GAD-7 scores over this time to see if the device is helpful. The current status of this study is unclear, and it plans to enroll 30 participants.", "design": "This is an open-label, single-arm study, meaning all 30 participants will receive the Sparrow Link device, and everyone will know what treatment they are getting. It is a decentralized study, so you will likely participate from home.", "commitments": "You would self-administer daily Sparrow Link sessions for 28 days. You will also complete daily and weekly online questionnaires for eight weeks (56 days), with weekly questionnaires taking no longer than 15 minutes.", "compensation": "Not stated in the trial record.", "follow_up": "You will be followed for 56 days, with the last GAD-7 measurement taken at Day 56.", }
- Study design
- Not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
tAN for First Responders
At a glance
Conditions
NCT07109349
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Spark Biomedical - DECENTRALIZED STUDY
Dallas, Texasstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Navid Khodaparast, PhD · PRINCIPAL_INVESTIGATOR · Spark Biomedical, Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- GAD-7Screening, Day 0, Day 14, Day 28, Day 42, Day 56
The GAD-7 is a valid and efficient tool for screening for GAD and assessing its severity in clinical practice and research. The questionnaire consists of 7 questions in which participants are asked to rate each item on a 0 (not at all) to 3 (nearly every day). GAD-7 total score for the seven items ranges from 0 to 21 where 0-4 represents minimal anxiety, 5-9 represents mild anxiety, 10-14 represents moderate anxiety and 15-21 represent severe anxiety.